Tenofovir Treatment Has Lower Risk of Hepatocellular Carcinoma than Entecavir Treatment in Patients with Chronic Hepatitis B: A Systematic Review and Meta-Analysis-MedSci.cn

Tenofovir Treatment Has Lower Risk of Hepatocellular Carcinoma than Entecavir Treatment in Patients with Chronic Hepatitis B: A Systematic Review and Meta-Analysis

Liu, HR; Shi, Y; Hayden, JC; Ryan, PM; Rahmani, J; Yu, GS

Yu, GS (corresponding author), Shandong First Med Univ, Shandong Prov Hosp, Dept Hepatobiliary Surg, 324 Jingwu Rd, Jinan 250021, Shandong, Peoples R China.

LIVER CANCER, 2020; 9 (4): 468

Abstract

Purpose:Tenofovir (TDF) and entecavir (ETV) are both equally recommended as first-line treatments for patients with chronic hepatitis B (CHB). They ha......

Full Text Link